Molecular pharmacology of ciclesonide against SARS-CoV-2
- PMID: 32593491
- PMCID: PMC7293530
- DOI: 10.1016/j.jaci.2020.05.029
Molecular pharmacology of ciclesonide against SARS-CoV-2
Figures
References
-
- Matsuyama S, Kawase M, Nao N, Shirato K, Ujike M, Kamitani W, et al. The inhaled corticosteroid blocks coronavirus RNA replication by targeting viral NSP15. BioRxiv 987016 [Preprint]. 2020. https://doi.org/10.1101/2020.03.11.987016. - DOI - PMC - PubMed
-
- Aso J, Kimura H, Ishii H, Saraya T, Kurai D, Matsushima Y, et al. Molecular evolution of the fusion protein (F) gene in human respirovirus 3 [published online ahead of print January 15, 2020]. Front Microbiol 2020;10:3054. https://doi.org/10.3389/fmicb.2019.03054. - DOI - PMC - PubMed
-
- Nave R., Meyer W., Fuhst R., Zech K. Formation of fatty acid conjugates of ciclesonide active metabolite in the rat lung after 4-week inhalation of ciclesonide. Pulm Pharmacol Ther. 2005;18:390–396. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous